INTUITIVE SURGICAL INC's gross profit margin for the fourth quarter of its fiscal year 2014 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased. INTUITIVE SURGICAL INC is extremely liquid. Currently, the Quick Ratio is 3.09 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has remained virtually unchanged only decreasing by 3.48% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY14||Q4 FY13|
|Net Sales ($mil)||604.7||576.2|
|Net Income ($mil)||146.8||166.2|
|Balance Sheet||Q4 FY14||Q4 FY13|
|Cash & Equiv. ($mil)||1232.5||1403.5|
|Total Assets ($mil)||3959.4||3950.3|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q4 FY14||Q4 FY13|
|Gross Profit Margin||68.41||72.21|
|Return on Assets||10.57||16.98|
|Return on Equity||12.39||19.16|
|Debt||Q4 FY14||Q4 FY13|
|Share Data||Q4 FY14||Q4 FY13|
|Shares outstanding (mil)||36.6||38.2|
|Div / share||0.0||0.0|
|Book value / share||92.33||91.66|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||242398.0||287963.0|
BUY. This stock's P/E ratio indicates a premium compared to an average of 39.81 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 19.41. Conducting a second comparison, its price-to-book ratio of 5.40 indicates a significant premium versus the S&P 500 average of 2.74 and a premium versus the industry average of 5.32. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, INTUITIVE SURGICAL INC proves to trade at a premium to investment alternatives within the industry.
|ISRG 44.59||Peers 39.81||ISRG 27.46||Peers 25.41|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
ISRG is trading at a premium to its peers.
Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
ISRG is trading at a valuation on par to its peers.
|ISRG 24.94||Peers 79.34||ISRG 0.77||Peers 0.91|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
ISRG is trading at a significant discount to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
ISRG trades at a discount to its peers.
|ISRG 5.40||Peers 5.32||ISRG -33.12||Peers -15.76|
Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
ISRG is trading at a valuation on par with its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, ISRG is expected to significantly trail its peers on the basis of its earnings growth rate.
|ISRG 8.57||Peers 6.98||ISRG -5.89||Peers 6.65|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ISRG is trading at a premium to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
ISRG significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV